Stryker Corporation (SYK)
Return on total capital
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 4,499,000 | 3,496,000 | 3,510,000 | 3,333,000 | 3,492,000 | 4,190,000 | 4,016,000 | 3,917,000 | 3,673,000 | 3,208,000 | 3,155,000 | 2,976,000 | 2,683,000 | 3,013,000 | 2,692,000 | 2,634,000 | 2,615,000 | 2,195,000 | 2,480,000 | 1,731,000 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 22,420,000 | 21,785,000 | 21,191,000 | 20,930,000 | 20,634,000 | 20,149,000 | 19,762,000 | 19,172,000 | 18,593,000 | 17,905,000 | 17,361,000 | 16,895,000 | 16,616,000 | 16,463,000 | 15,674,000 | 15,046,000 | 14,877,000 | 14,178,000 | 13,820,000 | 13,502,000 |
| Return on total capital | 20.07% | 16.05% | 16.56% | 15.92% | 16.92% | 20.80% | 20.32% | 20.43% | 19.75% | 17.92% | 18.17% | 17.61% | 16.15% | 18.30% | 17.17% | 17.51% | 17.58% | 15.48% | 17.95% | 12.82% |
December 31, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $4,499,000K ÷ ($—K + $22,420,000K)
= 20.07%
Peer comparison
Dec 31, 2025
Company name
Symbol
Return on total capital
Stryker Corporation
SYK
20.07%
Abbott Laboratories
ABT
17.01%
CONMED Corporation
CNMD
11.71%